Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Phytex Australia is a specialized pharmaceutical company focused on the extraction and purification of high-value alkaloids from plant sources. Based in Sydney, the company is a global leader in the production of tropane alkaloids, including scopolamine (hyoscine) and atropine, as well as other plant-derived active pharmaceutical ingredients (APIs). Phytex operates a GMP-compliant manufacturing facility and supplies its products to major pharmaceutical companies worldwide for use in various therapeutic applications. Their expertise lies in complex botanical extraction and large-scale chemical purification processes, positioning them as a critical supplier in the global pharmaceutical supply chain.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Phytex Australia.